Article
Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.
Pathology oncology research : POR - 1 Oct 2014
Sári Eszter, Nagy Zsolt György, Baghy Kornélia, Rajnai Hajnalka, Bödör Csaba, Csomor Judit, Barna Gábor, Rudas Gábor, Kovalszky Ilona, Demeter Judit
Abstract excerpt
Hairy cell leukemia is a rare chronic lymphoproliferative disorder with indolent but progressive clinical course. Patients require treatment when they have significant cytopenia or recurrent infections. The gold standard treatment are purine nucleoside analogues (cladribine and pentostatine), with these agents the rate of complete remission can approach even 95 %. The differential diagnosis between classical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.